The pharmacovigilance correspondent for blood-derived medicinal products mentioned in article
R. 5121-181is responsible within the establishment for dispensing and monitoring these medicinal products.
In health establishments, he/she takes part in the work of the transfusion safety and haemovigilance committee or the sub-committee responsible for transfusion safety and haemovigilance, under the conditions set out in article
R. 1221-46.
It is responsible for recording and storing information relating to blood-derived medicinal products, under the conditions set out in articles
R. 5121-187 to R. 5121-191and
R. 5121-195.
It receives and forwards to the regional pharmacovigilance centre, in accordance with article
R. 5121-197, reports of adverse reactions likely to be due to a blood-derived medicinal product which it has supplied. However, the regional centre receives reports directly relating to adverse reactions which may be due to a medicinal product supplied in the establishment in which this centre is based; it forwards a copy without delay to its correspondent in the establishment.
Pharmacovigilance correspondents for blood-derived medicinal products are subject to the good pharmacovigilance practices provided for in article
R. 5121-179.

